SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT)
United Kingdom·In Vitro Diagnostic Device·NZYTech·Registered Nov 28, 2022- Device ID
- 161891
- MHRA Reference Number
- 161891
- Date Registered
- Nov 28, 2022
- Last Updated
- Nov 29, 2022
- Device Type
- In Vitro Diagnostic Device
- Devices
- SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT)
- Type
- IVD General
- Name
- NZYTech
- Address
- Estrada do Paço do Lumiar, Campus do Lumiar, Edifício E – r/c Lisboa, Portugal
- Created Date
- Nov 28, 2022
- Relationship Type
- UK Responsible Person
- Address
- Dept 302, 43 Owston Road Carcroft Doncaster, England, United KingdomPostcode: DN6 8DA
Devices with a matching generic name or device type registered with MHRA
Additional devices registered by the same manufacturer
Additional devices represented by UKCA Experts Ltd. in the UK
SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT) is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 161891. The device is manufactured by NZYTech from Portugal, classified as In Vitro Diagnostic Device. The authorized representative in the UK is UKCA Experts Ltd..
This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.